The Filing Desk

Precigen vs Xenon Pharmaceuticals

Precigen PGEN · Xenon Pharmaceuticals XENE · Pharmaceuticals

Precigen reported revenue of $10 million in fiscal 2025, 1.3 times Xenon Pharmaceuticals' $8 million in fiscal 2025. Precigen had an operating margin of -1141.1%, against -4974.3% at Xenon Pharmaceuticals. Free cash flow was −$90 million at Precigen and −$280 million at Xenon Pharmaceuticals.

Side by side

PrecigenXenon Pharmaceuticals
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$10M$8M
Revenue growth146.7%—
Revenue growth a year, last 5 years−21.2%−25.3%
Gross margin——
Operating margin−1,141.1%−4,974.3%
Net margin−2,588.2%−4,612.1%
Free cash flow−$90M−$280M
Free cash flow margin−927.6%−3,732.2%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count16.9%1.7%
Last close$4.54$40.48
P/E at the last close45.4×—
Insider trades, last 12 months—sold $22.0 million
Piotroski F-score2 of 8—
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
PrecigenXenon Pharmaceuticals
Operating margin
Percent of revenue
PrecigenXenon Pharmaceuticals
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
PrecigenXenon Pharmaceuticals

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Precigen and Xenon Pharmaceuticals pages.